Cargando…

Analysis of Cellular Heterogeneity in Immune Microenvironment of Primary Central Nervous System Lymphoma by Single-Cell Sequencing

BACKGROUND: Primary central nervous system lymphoma (PCNSL) is characterized by a lack of specificity and poor prognosis. Further understanding of the tumor heterogeneity and molecular phenotype of PCNSL is of great significance for improving the diagnosis and treatment of this disease. METHODS: To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Boyuan, Liu, Zhe, Fan, Yue, Wang, Shuwei, Dong, Chao, Rao, Wei, Yang, Fan, Cheng, Gang, Zhang, Jianning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523033/ https://www.ncbi.nlm.nih.gov/pubmed/34671548 http://dx.doi.org/10.3389/fonc.2021.683007

Ejemplares similares

Primary Central Nervous System Lymphoma With Systemic Recurrence
por: Pandravada, Sasirekha, et al.
Publicado: (2021)

Recent Progress on Primary Central Nervous System Lymphoma—From Bench to Bedside
por: Shao, Liang, et al.
Publicado: (2021)

Relapsed Primary Central Nervous System Lymphoma: Current Advances
por: Tao, Kaiyan, et al.
Publicado: (2021)

Editorial: Advances in the treatment of primary central nervous system lymphoma
por: Qian, Liren, et al.
Publicado: (2023)

Socioeconomic deprivation and survival outcomes in primary central nervous system lymphomas
por: Deng, Xiangyang, et al.
Publicado: (2022)

Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma
por: Wu, Susan Y, et al.
Publicado: (2023)

The Role of BAFF-R Signaling in the Growth of Primary Central Nervous System Lymphoma
por: Zhou, Xiaolan, et al.
Publicado: (2020)

Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients
por: Cheng, Gang, et al.
Publicado: (2018)

Modelling the central nervous system: tissue engineering of the cellular microenvironment
por: Walczak, Paige A., et al.
Publicado: (2021)

Identification of key mutations in central nervous diffuse large B-cell lymphoma (DLBCL) by comprehensive analysis between sequencing and TCGA database
por: Zhou, Chunhui, et al.
Publicado: (2021)

Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry
por: Mocikova, Heidi, et al.
Publicado: (2022)

Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy
por: Luo, Qian, et al.
Publicado: (2021)

Epidemiologic Characteristics, Prognostic Factors, and Treatment Outcomes in Primary Central Nervous System Lymphoma: A SEER-Based Study
por: Tang, Dongsheng, et al.
Publicado: (2022)

Real-World Impact of Surgical Excision on Overall Survival in Primary Central Nervous System Lymphoma
por: Deng, Xiangyang, et al.
Publicado: (2020)

Successes and challenges in modeling heterogeneous BRAF(V600E) mutated central nervous system neoplasms
por: Xing, Yao Lulu, et al.
Publicado: (2023)

The role of preoperative inflammatory markers in patients with central nervous system tumors, focus on glioma
por: Chen, Fan, et al.
Publicado: (2022)

Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma
por: Xu, Tianqi, et al.
Publicado: (2021)

Development of a Multicellular 3D Tumor Model to Study Cellular Heterogeneity and Plasticity in NSCLC Tumor Microenvironment
por: Arora, Leena, et al.
Publicado: (2022)

Complete Blood Count Score Model Predicts Inferior Prognosis in Primary Central Nervous System Lymphoma
por: Feng, Yuhua, et al.
Publicado: (2021)

Impact of Central Nervous System International Prognostic Index on the Treatment of Diffuse Large B Cell Lymphoma
por: Ma'koseh, Mohammad, et al.
Publicado: (2021)

Bruton’s tyrosine kinase inhibitors in the treatment of primary central nervous system lymphoma: A mini-review
por: Shen, Jing, et al.
Publicado: (2022)

Primary Central Nervous System Lymphoma  with Peripheral Nerve Involvement:  Case Report
por: Mori, Yoshimasa, et al.
Publicado: (2019)

Stereotactic Radiotherapy for Recurrent Post-Transplant Primary Central Nervous System Lymphoma
por: Benitez, Cecil M, et al.
Publicado: (2021)

Local Control of Primary Dural Central Nervous System Lymphoma Achieved With Radiotherapy
por: Vallejo, Alexandra, et al.
Publicado: (2021)

Microenvironment Cell Contribution to Lymphoma Immunity
por: Kumar, Deepika, et al.
Publicado: (2018)

Comparison of Radiomics-Based Machine-Learning Classifiers in Diagnosis of Glioblastoma From Primary Central Nervous System Lymphoma
por: Chen, Chaoyue, et al.
Publicado: (2020)

MicroRNAs as Diagnostic Biomarkers in Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
por: Zheng, Xiaohong, et al.
Publicado: (2021)

Efficacy and Safety of Ibrutinib in Central Nervous System Lymphoma: A PRISMA-Compliant Single-Arm Meta-Analysis
por: Lv, Liwei, et al.
Publicado: (2021)

Editorial: Tumour microenvironment heterogeneity in hematological malignancies
por: Deaglio, Silvia, et al.
Publicado: (2023)

A key driver to promote HCC: Cellular crosstalk in tumor microenvironment
por: Liu, Pengyue, et al.
Publicado: (2023)

A novel inflammation-related prognostic model for predicting the overall survival of primary central nervous system lymphoma: A real-world data analysis
por: Wu, Zhentian, et al.
Publicado: (2023)

The Efficacy and Safety of Cytarabine on Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
por: Zheng, Xiaohong, et al.
Publicado: (2020)

Non-cancer-specific survival in patients with primary central nervous system lymphoma: A multi-center cohort study
por: Chi, Kaiyi, et al.
Publicado: (2023)

Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphoma
por: Yang, Yu, et al.
Publicado: (2023)

Reveal the Heterogeneity in the Tumor Microenvironment of Pancreatic Cancer and Analyze the Differences in Prognosis and Immunotherapy Responses of Distinct Immune Subtypes
por: Wang, Xiaoqin, et al.
Publicado: (2022)

Corrigendum: Microenvironment Cell Contribution to Lymphoma Immunity
por: Kumar, Deepika, et al.
Publicado: (2018)

The Role of Rituximab in Primary Central Nervous System Lymphoma
por: Bromberg, Jacoline E. C., et al.
Publicado: (2020)

Brain Microenvironment Heterogeneity: Potential Value for Brain Tumors
por: Álvaro-Espinosa, Laura, et al.
Publicado: (2021)

The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
por: Worzfeld, Thomas, et al.
Publicado: (2017)

Shaping Up the Tumor Microenvironment With Cellular Fibronectin
por: Efthymiou, Georgios, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6c8lb2hep4l8iu5vsjud5ljpdt